Showing results (161-170 of 211) with videos related to

Sort By:
Pageof 22
CA: a Cancer Journal for Clinicians|August 28, 2020
Onconephrology: The intersections between the kidney and cancerMitchell H Rosner, Kenar D Jhaveri, Blaithin A McMahon, et al.
The Journal of Rheumatology|August 19, 2010
LupusQoL-US benchmarks for US patients with systemic lupus erythematosusMeenakshi Jolly, Simon A Pickard, Rachel A Mikolaitis, et al.
Nature Reviews. Nephrology|September 28, 2022
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injuryBen Sprangers, David E Leaf, Camillo Porta, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Addition of sertraline to other therapies to reduce dialysis-associated hypotensionUrsula C Brewster, Marc A Ciampi, Ali K Abu-Alfa, et al.
Kidney International|March 25, 2026
Conventional cytotoxic chemotherapy-associated nephrotoxicityMark A Perazella, Lui Forni, Paolo Lentini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2008
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USAAndrew J Palmer, William J Valentine, Roland Chen, et al.
Drugs in R&D|August 5, 2015
Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial DataRoger A Rodby, Kausik Umanath, Robert Niecestro, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 12, 2008
Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patientsMark A Perazella, Steven G Coca, Mehmet Kanbay, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2008
Serum vasopressin response in patients with intradialytic hypotension: a pilot studyMira Rho, Mark A Perazella, Chirag R Parikh, et al.
Kidney International Reports|September 12, 2022
Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical TrialsBen Sprangers, Mark A Perazella, Stuart M Lichtman, et al.
Pageof 22